Skip to main content
SpringerLink
Log in

Safety of immune checkpoint inhibitors analysed

  • Review
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. as only one study was available.

  2. including pruritus, rash, diarrhoea, colitis, hypothyroidism, hyperthyroidism, and pneumonitis.

  3. had non-overlapping toxicity results

Reference

  • Xu C, et al. Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis. BMJ 363: [16 pages], 8 Nov 2018. Available from: URL: https://doi.org/10.1136/bmj.k4226

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Safety of immune checkpoint inhibitors analysed. Reactions Weekly 1728, 11 (2018). https://doi.org/10.1007/s40278-018-54274-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-54274-2

Search

Navigation